OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
OraSure Technologies announced FDA clearance for its Colli-Pee™•Dx Urine Collection Kit, manufactured by subsidiary DNA Genotek. The kit allows for at-home self-collection of first-void urine samples, which are compatible with Roche’s cobas® molecular diagnostic systems for testing Chlamydia, Gonorrhea, Trichomonas, and Mycoplasma genitalium.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.